• Register
  • Login
  • Subscribe
  • Contact Us

Price Record for Eventual and Future Acquisition of Generic Medicines for Prophylactic and Therapeutic Treatment of Patients with Suspicion and Confirmation of Cuvid-19.

BrazilTenders notice for Price Record for Eventual and Future Acquisition of Generic Medicines for Prophylactic and Therapeutic Treatment of Patients with Suspicion and Confirmation of Cuvid-19.. The reference ID of the tender is 51572299 and it is closing on 06 Apr 2021.

Tender Details

  • Country: Brazil
  • Summary: Price Record for Eventual and Future Acquisition of Generic Medicines for Prophylactic and Therapeutic Treatment of Patients with Suspicion and Confirmation of Cuvid-19.
  • BRT Ref No: 51572299
  • Deadline: 06 Apr 2021
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 4/2021
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Object: Electronic Trading - Price record for eventual and future acquisition of generic medicines for prophylactic and therapeutic treatment of patients with suspicion and confirmation of Cuvid-19. UASG Code: 984273
    Notice from 08/23/2021 from 08:00 to 11:00 and from 13:00 to 17:59 Hs Delivery of the proposal: from 23/03/2021 at 08:00 p.m. Azithromycin, 40 mg / ml dosing, oral suspension presentation Quantity: 720
    Azithromycin, Dosage 500 mg Quantity: 12600
    Sodium dipyrone, dosing 500 mg Quantity: 504
    Enoxaparina, concentration 100 mg / ml, pharmaceutical form Injectable solution, additional features 1 syringe filled in Quantity: 720
    Nitazoxanida, concentration 500 mg Quantity: 7200
    Paracetamol, tablet dosage 500 mg Quantity: 504
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Price Record for Eventual and Future Acquisition of Generic Medicines for Prophylactic and Therapeutic Treatment of Patients with Suspicion and Confirmation of Cuvid-19. - Brazil Tender

The MUNICIPALITY OF CARLOS CHAGAS / MG, a Government sector organization in Brazil, has announced a new tender for Price Record for Eventual and Future Acquisition of Generic Medicines for Prophylactic and Therapeutic Treatment of Patients with Suspicion and Confirmation of Cuvid-19.. This tender is published on BrazilTenders under BRT Ref No: 51572299 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-04-06.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

BrazilTenders Features

BrazilTenders Features

Fresh and verified Tenders from Brazil. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting BrazilTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Brazil in your email inbox.

  Chat with us